Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 24/4/2019
SIETES contiene 92718 citas

 
 
 1 a 20 de 53 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page II RL, Goldstein LB, Chin C, Tannock LR, Miller M, Raghuveer G, Duell PB, Brinton EA, Pollak A, Braun LT, Welty FK. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 2019;39:enero. [Ref.ID 103011]
2.Tiene citas relacionadas Cita con resumen
Curfman G. Risks of statin therapy in older adults. JAMA Intern Med 2017;177:966. [Ref.ID 101591]
3. Cita con resumen
Ezquerra Pérez G, Martín de la Nava MA, Álvarez-Cienfuegos A, Montaño Barrientos A, Baquero Barroso MJ, Rubio Núñez PL, Gómez Santana MC, Gavilán Moral E, Candela Marroquín E, Sánchez Robles GA. Revisión GRADE de estatinas en población con = 90% en prevención primaria cardiovascular. Sección 3: Efectos adversos. II. Miopatías.. Grupo Evalmed-GRADE 2016:21 de enero. [Ref.ID 99983]
4. Cita con resumen
Finegold JA, Manisti CH, Goldacre B, Barron AJ, Francis DP. What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice. European Journal of Preventive Cardiology 2014;21:464-74. [Ref.ID 97504]
5.Tiene citas relacionadas
Ray KK, Seshasai SRK, Jukema W, Sattar N. Are statins effective in high-risk primary prevention? In reply. Arch Intern Med 2010;170:2043-4. [Ref.ID 89793]
6.Tiene citas relacionadas
Dentali F, Guasti L. Are statins effective in high-risk primary prevention?. Arch Intern Med 2010;170:2042-3. [Ref.ID 89792]
7.Enlace a cita original Cita con resumen
Garcia F, Montero Alonso MJ, Merino Senovilla A, Sanz Cantalapiedra R, Maderuelo JA. Las cifras mágicas en la prevención farmacológica de la enfermedad cardiovascular y de fracturas. Boletín de Información Farmacoterapéutica de Navarra 2009;17:49-63. [Ref.ID 87090]
8.Tiene citas relacionadas
Hippilsley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008;336:1475-82. [Ref.ID 83403]
9.Tiene citas relacionadas Cita con resumen
Christiaens T. Cardiovascular risk tables. BMJ 2008;336:1445-6. [Ref.ID 83394]
10.Tiene citas relacionadas
Kearney PM, Keech A, Simes J, Collins R, Baigent C, on behalf of the Cholesterol Treatment Trialists' (CTT) Collaboration. Statins and diabetes. Authors' reply. Lancet 2008;371:1752. [Ref.ID 82975]
11.Tiene citas relacionadas
Feeman Jr WE. Statins and diabetes. Lancet 2008;371:1752. [Ref.ID 82974]
12.Tiene citas relacionadas Cita con resumen
Goldstein MR, Mascitelli L, Pezzetta F. Cholesterol, statins, and mortality. Lancet 2008;371:1161. [Ref.ID 82572]
13.Tiene citas relacionadas Cita con resumen
Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trial of statins: a meta-analysis. Lancet 2008;371:117-25. [Ref.ID 81962]
14.Tiene citas relacionadas Cita con resumen
Cheung BMY. Statins for people with diabetes. Lancet 2008;371:94-5. [Ref.ID 81960]
15.Tiene citas relacionadas
Bellloto Jr RJ. On statins, strokes, meta-analyses, competing risks, and the onward march of science. Ann Pharmacother 2007;41:2055-7. [Ref.ID 81800]
16.Tiene citas relacionadas Cita con resumen
Henyan NN, Riche DM, East HE, Gann PN. Impact of statins on risk of stroke: a meta-analysis. Ann Pharmacother 2007;41:1937-45. [Ref.ID 81798]
17. Cita con resumen
Mangin D, Sweeney K, Heath I. Preventive health care in elderly people needs rethinking. BMJ 2007;335:285-7. [Ref.ID 80889]
19. Cita con resumen
Thavendiranathan P, Bagai A, Brookhart MA, Choudhry NK. Primary prevention of cardiovascular diseases with statin therapy. A meta-analysis of randomized controlled trials. Arch Intern Med 2006;166:2307-13. [Ref.ID 78694]
20.Tiene citas relacionadas Cita con resumen
Sirtori CR, Calabresi L. Japan: are statins still good for everybody?. Lancet 2006;368:1135-6. [Ref.ID 78171]
Seleccionar todas
 
 1 a 20 de 53 siguiente >>